Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss why he's cautious on Apple and the market ...

BTIG says a “considerable amount of our time is spent thinking and talking about” Fannie Mae (FNMA) and Freddie Mac (FMCC) because those ...

BTIG said it would be cautious on Apple's (NASDAQ:AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the ...

On Friday, Cerus Corp (CERS) stock saw a decline, ending the day at $1.56 which represents a decrease of $-0.10 or -6.02% from the prior close of $1.66. The stock opened at $1.65 and touched a low of ...

Lennar (LEN – Research Report) received a Hold rating and price target from BTIG analyst Carl Reichardt yesterday. The company’s shares ...

BTIG raised the firm’s price target on Darden (DRI) to $205 from $195 and keeps a Buy rating on the shares after its Q2 ...

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at BTIG, in a note. “Brinker International (EAT) is not in the S&P 500 ...

From "Apple Stock Hasn’t Had a Streak Like This Since 2010. What It Means as Value Nears $4 Trillion." posted Thursday by ...

Ready Capital Corp (RC) stock saw a decline, ending the day at $7.35 which represents a decrease of $-0.04 or -0.54% from the prior close of $7.39. The stock opened at $7.31 and touched a low of $7.26 ...

BTIG initiated coverage of Cartesian Therapeutics (RNAC) with a Buy rating and $42 price target Cartesian is pioneering the field of mRNA-based CART cell therapies for autoimmune disorders, the ...

BTIG analyst Jeet Mukherjee initiated coverage of Arvinas (ARVN) with a Buy rating and $69 price target The company’s lead program, vepdegestrant, is a potent ER degrader for being developed for ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...